Researchers at the University of Naples Federico II, in Italy, conducted a study to investigate the effect of CBD on intestinal inflammation and hypermotility in mice. The mice were first treated with dinitrobenzenesulfonic acid (DNBS) to induce both intestinal inflammation and hypermotility. After administering CBD, researchers noted that the damage caused by the DNBS, measured by inflammation and hypermotility levels, decreased. Their findings sustained the claims that CBD could reduce injury and inflammation to the intestines, as well as, aid in hypermotility.
We encourage further independent research and clinical trials involving cannabidiol. For those suffering from intestinal complications, CBD may offer a natural, well-tolerated option to help soothe an already irritated system.
To read more on the aforementioned study, click here.